Business Segment Information (Tables)

3 Months Ended

Jul. 31, 2013

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The following tables summarize, for the periods indicated, operating results by business segment (in thousands):

Three Months Ended July 31, 2013	Personalized Oncology Solutions (POS)		Translational Oncology Solutions (TOS)		Unallocated Corporate Overhead		Consolidated
Net revenue	$	622	$	2,398	$	-	$	3,020
Direct cost of services		(744)		(872)		-		(1,614)
Sales and marketing costs		(333)		(246)		-		(579)
Other operating expenses		-		(389)		(652)		(1,041)
Stock- based compensation expense (1)		-		-		(552)		(552)

Segment profit (loss)	$	(456)	$	891	$	(1,204)	$	(766)

Three Months Ended July 31, 2012	Personalized Oncology Solutions (POS)		Translational Oncology Solutions (TOS)		Unallocated Corporate Overhead		Consolidated
Net revenue	$	918	$	1,188	$	-	$	2,106
Direct cost of services		(717)		(691)		-		(1,408)
Sales and marketing costs		(435)		(192)		-		(627)
Other operating expenses		-		(363)		(568)		(931)
Stock- based compensation expense (1)		-		-		(739)		(739)

Segment profit (loss)	$	(234)	$	(58)	$	(1,307)	$	(1,599)

(1) Stock compensation expense is shown separately and is excluded from direct costs of services, sales and marketing costs, and other operating expenses, as it is managed on a consolidated basis and is not used by management to evaluate the performance of its segments.

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details